Akebia Therapeutics Inc logo

Akebia Therapeutics Inc

NEW
STU:AX9 (USA)  
€ 1.1255 +0.046 (+4.31%) Jul 6
At Loss
P/B:
12.75
Market Cap:
€ 306.23M ($ 350.14M)
Enterprise V:
€ 208.21M ($ 238.06M)
Volume:
1.04K
Avg Vol (2M):
56.37K
Trade In:
Volume:
1.04K
At Loss
Avg Vol (2M):
56.37K

Akebia Therapeutics Inc (STU:AX9) Dividend

Akebia Therapeutics Inc (STU:AX9) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:AX9 Dividend

Does Akebia Therapeutics Inc (STU:AX9) pay a dividend?

Akebia Therapeutics Inc (STU:AX9) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Akebia Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Akebia Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -13% over the past 3 years.

What are dividend-paying alternatives to Akebia Therapeutics Inc?

For dividend-paying alternatives in Akebia Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.